ELDRED KARY bought GALT

July 21, 2025 · Form 4 insider transaction

ELDRED KARY bought 1,000 shares of Galectin Therapeutics Inc. at $2.92 per share, a transaction worth $2.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
1,000
Price
$2.92
Total value
$2.9K
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJuly 21, 2025
Filing dateJuly 22, 2025
Shares owned after64,682
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR